$VERU - Just Added...Now 2/5 position

Got a very tight stop/loss on this one, right below the trendline at $11.75. Just added more. I like the walk up the trendline. I bought a few days ago off the Slow Stochastics which triggered me to nibble.

$VERU daily chart


More on $VERU


The company has recently published strong positive results from its phase 3 trial of sabizabulin, an antiviral and anti-inflammatory drug for treating severe cases of Covid-19. As a result of the “overwhelming efficacy” that halved the risk of death among patients, Veru is seeking an Emergency Use Authorization (EUA) for sabizabulin from the FDA. Understandably, Veru investors are excited about the possibility of getting an EUA.

VERU stock has skyrocketed 100% YTD. Shares are trading at 19.5 times sales. Meanwhile, analysts’ 12-month median price target stands at $31.

1 Like